Models:
Joseph Gordon
joseph-gordon/
ClinicalTrialsElig
0
Downloads: 1
[c09aa8]: / clusters / ordered9kclusters / clust_934.txt

Download this file

278 lines (277 with data), 7.8 kB 

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
Leukocytes >= 2,500/mcL

Leukocytes >= 1,500/mcL

Leukocytes >= 2,500/mcL, within 2 weeks of randomization

Leukocytes >= 3,000/mcL

Within 14 days of treatment initiation: Leukocytes >= 2,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL within 4 weeks before randomization

Leukocytes >= 3,000/mcL

leukocytes ?3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes ? 3,000/mcL within 14 days of registration

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes ? 3,000/mcL

Leukocytes >= 3,000/mcL (>= 3,000/mm^3)

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes > 3,000/mcL

Leukocytes >= 3,000/mcL

ENDOCRINE RESISTANT AND ADJUVANT COHORT: Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

Leukocytes > 3,000/mcL

Leukocytes ? 3,000/mcL

Obtained within 21 days prior to study registration: leukocytes >= 3,000/mcL

Leukocytes >= 2,500/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 1,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcl

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Within 2 weeks prior to initiation of study treatment: Leukocytes >= 3,000/mcL

COHORT I: Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes ? 2,000/mcL

Leukocytes >= 3,000/mcL.

Leukocytes >= 3,000/mcL, =< 5 days prior to cycle 1 (C1) day 1 (D1)

Leukocytes >= 3,000/mcL.

Leukocytes >= 3,000/mcL

Leukocytes > 3,000/mcL

Leukocytes >= 3,000/mcL.

Leukocytes >= 3,000/mcL

Leukocytes >= 2,500/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL within 14 days of treatment initiation

Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

Obtained within 21 days of registration: leukocytes > 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL 14 days or fewer from registration

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL (without growth factor)

Leukocytes >= 3,000/mcL

Leukocytes >= 1500/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 1500/mcL, within 14 days prior to treatment

Leukocytes >= 3000 mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

Leukocytes >= 3,000/mcL

PHASE II: Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Within 14 days prior to registration: Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL, obtained within 14 days of first dose of drug

PHASE I: Leukocytes >= 3,000/mcL

PHASE II SCLC: Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes: >= 3,000/mcl (lymphocyte [lymph] %: >= 10%)

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,500/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes < 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes > 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes > 1,500/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Within 4 weeks of preregistration: Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >3,000/mcL

Leukocytes ? 2,500/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

Leukocytes >= 1,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,500/mcL

Leukocytes >= 3,000/mcL

Leukocytes > 1,500/mcL

Leukocytes >= 3,000/mcL

DOSE EXPANSION COHORT: Leukocytes ? 3,000/mcL

Leukocytes >= 3,000/mcL

Measured within 28 days prior to administration of study treatment: Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

Leukocytes >= 3,500/mcL

Within 14 days of registration: Leukocytes >= 2,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

PHASE II: Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,500/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL; these results must be obtained within 28 days prior to registration

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

Obtained within 30 days of registration: Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL, within 14 days of study registration

Leukocytes >= 2,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes > 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes greater than 3,000/mcL

Leukocytes >= 3,000/mcL

PHASE I: Leukocytes >= 3,000/mcL

PHASE II: Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

PART B: Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes > 3,000/mcL

REGISTRATION INCLUSION CRITERIA: Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes ? 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes ? 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,500/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes > 1,500/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,00/mcL

Performed within 10 days of treatment initiation: Leukocytes >= 2,000/mcL

Leukocytes > 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,500/mcL

Leukocytes >= 2,500/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3 K/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 2,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes > 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL (within 14 days of study registration)

Leukocytes >= 3,000/mcL

Leukocytes ? 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes >= 3,000/mcL

Leukocytes > 3,000/mcL

Leukocytes > 3,000/mcL

Leukocytes > 3,000/mcL

Leukocytes >= 3,000/mcL